Amoeba (PAR: ALMIB)

Currency in EUR

Last close As at 09/06/2023

EUR0.59

0.00 (0.17%)

Market capitalisation

EUR29m

Amoéba is developing biological fungicides for treating diseases such as mildews and rusts, which have a major economic impact on the production globally of a wide range of crops. These novel fungicides are based on the characteristics of the Willaertia magna C2c Maky amoeba.

As noted in the March press release, the company is not yet revenue generating. Grant income was €0.1m lower year-on-year in FY22, while total operating costs were €0.2m higher year-on-year, resulting in a widening of EBIT losses by €0.3m to €5.8m. The company moved from €5.2m net debt at the end of FY21 to €3.2m net cash at the end of FY22. The primary reason for this was the €10.6m cash inflow generated from the issue of several tranches of convertible bonds associated with a finance programme with Nice & Green. This programme also resulted in a jump in net assets from €0.2m at end FY21 to €8.2m at end FY22.

Latest Insights

View More

Industrials

Amoeba — Scaling up for commercialisation

Industrials

Amoeba — Building on an exceptional year

Industrials

Amoeba – executive interview

Industrials

Amoeba — Fighting pathogens, respecting nature

Sector

Industrials

Equity Analyst

Natalya Davies

Natalya Davies

Associate Analyst

Key Management

  • Fabrice Plasson

    Chairman & CEO

  • Jean-Francois Doucet

    Deputy general manager

Balance Sheet

Forecast net debt (€m)

9.7

Forecast gearing ratio (%)

746

Share Price Performance

Price Performance
% 1M 3M 12M
Actual 0.5 (17.9) 3.3
Relative 3.3 (16.4) (6.2)
52 week high/low €1.2/€0.5

Financials

Following on from the press release in March, which provided preliminary data on the FY22 results, Amoéba has published its FY22 universal registration document, which contains detailed financial information for the year. We leave our FY23 estimates unchanged.

Y/E Dec Revenue (€m) EBITDA (€m) PBT (€m) EPS (fd) (c) P/E (x) P/CF (x)
2021A 0.0 (4.0) (7.4) (41.62) N/A N/A
2022A 0.0 (4.7) (7.7) (22.99) N/A N/A
2023E 0.0 (7.7) (9.1) (18.43) N/A N/A
2024E N/A N/A N/A N/A N/A N/A

Research

TMT

ESG, moving beyond the box tick

Industrials

A new paradigm for space

Industrials

The emergence of mega-constellations

Industrials

Internet in the sky

Industrials

Truth creates light

Industrials

All-seeing eye in the sky

Consumer

Circular economy business models

Industrials

BayWa – Focus on sustainability

Industrials

Investment themes: IPO boom in London

Industrials

The circular economy

Industrials

EV outlook #1 – Growth, policy and net zero

Industrials

Water – The real liquidity crisis

Industrials

Greece – Changing the narrative

Consumer

Illuminator: August Update

Industrials

Renewables rising – Sector primer

Industrials

German Mittelstand Conference

Industrials

German industrials: Global ambitions

Industrials

DSEi: Feedback and thoughts